ABC | Volume 114, Nº4, April 2020

Statement Luso-Brazilian Position Statement on Hypertensive Emergencies – 2020 Arq Bras Cardiol. 2020; 114(4)736-751 62. Andersen ND, Ganapathi AM, Hanna JM, Williams JB, Gaca JG, Hughes GC. Outcomes of acute type a dissection repair before and after implementation of a multidisciplinary thoracic aortic surgery program. J Am Coll Cardiol. 2014;63(17):1796-803. 63. NienaberCA,Powell JT.Management ofacuteaorticsyndromes.Eur Heart J. 2012;33(1):26-35b. 64. Erbel R, Aboyans V, Boileau C, Bossone E, Bartolomeu RD, Eggerecht H, et al. 2014 ESCGuidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2014;35(41):2873-926. 65. Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE Jr, et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVMGuidelines for the diagnosis andmanagement of patients with thoracic aortic disease. A Report of the American College of Cardiology Foundation/American Heart AssociationTaskForce onPracticeGuidelines, AmericanAssociation for Thoracic Surgery, American College of Radiology,American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons,and Society for Vascular Medicine. J Am Coll Cardiol. 2010;55(14):e27-e129. 66. Fattori R, Tsai TT, Myrmel T, Evangelista A, Cooper CV, Trimarchi S, et al. Complicated acute type B dissection: is surgery still the best option?: a report from the International Registry of Acute Aortic Dissection. JACC Cardiovasc Interv. 2008;1(4):395-402. 67. Suzuki T, Isselbacher EM, Nienaber CA, Ryeritz RE, eagle KA, Tsai T, et al. Type-selective benefits of medications in treatment of acute aortic dissection (from the International Registry of Acute Aortic Dissection [IRAD]). Am J Cardiol. 2012;109(1):122-7. 68. Takeshita S, Sakamoto S, Kitada S, Akutsu K, Hashimoto H. Angiotensin- converting enzyme inhibitors reduce long-term aortic events in patients with acute type B aortic dissection. Circ J. 2008;72(11):1758-61. 69. Wemmelund H, Hogh A, Hundborg HH, Thomsen RW, Johnsen SP, Lindholt JS. Statin use and rupture of abdominal aortic aneurysm. Br J Surg. 2014;101(8):966-75. 70. Alexander JM,Wilson KL. Hypertensive emergencies of pregnancy. Obstet Gynecol Clin North Am. 2013;40(1):89-101. 71. Deak TM, Moskovitz JB. Hypertension and pregnancy. Emerg Med Clin North Am. 2012;30(4):903-17. 72. MalachiasMV, Figueiredo CE, Sass N, Antonello IC, Torloni MR, Bortolotto ML. 7th Brazilian Guideline of Arterial Hypertension: Chapter 9 - Arterial Hypertension in pregnancy. Arq Bras Cardiol. 2016;107(3 Suppl 3):49-52. 73. Sibai BM, Grossman RA, Grossman HG. Effects of diuretics on plasma volume in pregnancies with long-termhypertension. Am J Obstet Gynecol. 1984;150(7):831-5. 74. Ramachandran R, Rewari V. Current perioperative management of pheochromocytomas. Indian J Urol. 2017;33(1):19-25. 75. Malachias MVB, Bortolotto LA, Drager LF, Borelli FAO, Lotaif LAD, Martins LC. 7th Brazilian Guideline of Arterial Hypertension: Chapter 12 - Secondary Arterial Hypertension. Arq Bras Cardiol. 2016;107(3 Suppl 3):67-74. 76. Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(6):1915-42. 77. Plouin PF, Amar L, Dekkers OM,Fassnacht M, Gimenez-Roqueplo AP, Lenders JW, et al. European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma. Eur J Endocrinol. 2016;174(5):G1-G10. 78. Muscholl E. Effect of cocaine and related drugs on the uptake of noradrenaline by heart and spleen. Br J Pharmacol Chemother. 1961;16:352-9. 79. Foltin RW, Ward AS, Haney M, Hart CL, Collins ED. The effects of escalating doses of smoked cocaine in humans. Drug Alcohol Depend. 2003;70(2):149-57. 80. Foltin RW, Fischman MW. Ethanol and cocaine interactions in humans: cardiovascular consequences. Pharmacol Biochem Behav. 1988;31(4):877-83. 81. Wilbert-Lampen U, Seliger C, Zilker T, Arendt RM. Cocaine increases the endothelial release of immunoreactive endothelin and its concentrations in human plasma and urine: reversal by coincubationwith sigma-receptor antagonists. Circulation. 1998;98(5):385-90. 82. Mo W, Singh AK, Arruda JA, Dunea G. Role of nitric oxide in cocaine- induced acute hypertension. Am J Hypertens. 1998;11(6 Pt 1):708-14. 83. Brogan WC, 3rd, Lange RA, Kim AS, Moliterno DJ, Hillis LD. Alleviation of cocaine-induced coronary vasoconstriction by nitroglycerin. J AmColl Cardiol. 1991;18(2):581-6. 84. Lange RA, Cigarroa RG, Flores ED, McBride W, Kim AS, Wells PJ, et al. Potentiation of cocaine-induced coronary vasoconstriction by beta- adrenergic blockade. Ann Intern Med. 1990;112(12):897-903. 85. Aronson S. Perioperative hypertensive emergencies. Curr Hypertens Rep. 2014;16(7):448. 86. Varon J, Marik PE. Perioperative hypertension management. Vasc Health Risk Manag. 2008;4(3):615-27. 87. GoldbergME, Larijani GE. PerioperativeHypertension. Pharmacotherapy: J Human Pharmacol Drug Ther.1998;18(5):911-4. 88. Rose DK, Cohen MM, DeBoer DP. Cardiovascular events in the postanesthesia care unit: contribution of risk factors. Anesthesiology. 1996;84(4):772-81. 89. Marik PE, Varon J. Perioperative hypertension: a review of current and emerging therapeutic agents. J Clin Anesth. 2009;21(3):220-9. 90. Goldman L, CalderaDL. Risks of general anesthesia and elective operation in the hypertensive patient. Anesthesiology. 1979;50(4):285-92. 91. Leslie JB. Incidence and aetiology of perioperative hypertension. Acta Anaesthesiol Scand Suppl. 1993;99:5-9. 92. Lien SF, Bisognano JD. Perioperative Hypertension: Defining At-Risk PatientsandTheirManagement.CurrHypertensRep.2012;14(5):432-41. 93. Wong JH, Findlay JM, Suarez-Almazor ME. Hemodynamic instability after carotid endarterectomy: risk factors and associations with operative complications. Neurosurgery. 1997;41(1):35-41; discussion 41-33. 94. StonehamMD, Thompson JP. Arterial pressure management and carotid endarterectomy. BJA. 2009;102(4):442-52. 95. Sigaudo-Roussel D, Evans DH, Naylor AR, Panerai R. Deterioration in carotid baroreflex during carotid endarterectomy. J Vasc Surg. 2002;36(4):793-8. 96. Nouraei SA, Al-Rawi PG, Sigaudo-Roussel D, Giussani DA, Gaunt ME. Carotid endarterectomy impairs blood pressure homeostasis by reducing the physiologic baroreflex reserve. J Vasc Surg. 2005;41(4):631-7. 97. Smith BL. Hypertension following carotid endarterectomy: the role of cerebral renin production. J Vasc Surg. 1984;1(5):623-7. 98. Hans SS, Prakash S, Hans P, Glover JL. The role of renin and catecholamine production in postcarotid endarterectomy hypertension. Surg Gynecol Obstet. 1992;174(3):201-4. 99. SealyWC.Paradoxicalhypertensionafterrepairofcoarctationoftheaorta: a review of its causes. Ann Thorac Surg. 1990;50(2):323-9. 750